Atlas Trials

Bronchoalveolar Cell Lung Cancer

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Bronchoalveolar Cell Lung Cancer

RecordFirmDate
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (NCT03896958)SpeciCare2019-03-21
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT01557959)Wake Forest University Health Sciences2007-07-01
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00368992)National Cancer Institute (NCI)2006-08-01
Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer (NCT00118144)National Cancer Institute (NCI)2005-06-01
Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery (NCT00049543)National Cancer Institute (NCI)2002-09-01
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer (NCT00021060)National Cancer Institute (NCI)2002-08-01
Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00040794)National Cancer Institute (NCI)2002-05-01
Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00029003)National Cancer Institute (NCI)2001-12-01
Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT00020709)National Cancer Institute (NCI)2001-06-01
Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer (NCT00002852)National Cancer Institute (NCI)1996-10-01

Track Bronchoalveolar Cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.